Incentives and disincentives to participation by clinicians in randomised controlled trials

被引:92
作者
Rendell, J. M. [1 ]
Merritt, R. K. [1 ]
Geddes, J. R. [1 ]
机构
[1] Univ Oxford, Warneford Hosp, Dept Psychiat, Oxford OX3 7JX, England
来源
COCHRANE DATABASE OF SYSTEMATIC REVIEWS | 2007年 / 02期
关键词
D O I
10.1002/14651858.MR000021.pub3
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Patients and clinicians need reliable, up-to-date information from randomised controlled trials (RCTs) on the costs and benefits of treatments. Recruitment difficulties arise when clinicians do not invite patients to participate in trials. Objectives Primary: to assess the evidence for the effect of disincentives and incentives on the extent to which clinicians invite eligible patients to participate in RCT; of healthcare interventions. Secondary: to assess the evidence in relation to stated willingness to invite participation. Search strategy 1. The Cochrane Methodology Register and Cochrane Database of Methodology Reviews were searched in May 2006 and Cochrane Central Register of Controlled Trials, National Research Register and ClinicalTrialsGov in April 2005. 2. EMBASE, MEDLINE, CINAHL, PsycINFO and AMED were searched in April 2005. 3. Reference lists of included studies were checked. Selection criteria Studies exploring the effect of (dis)incentives on clinicians' views and recruitment-related activity. Data collection and analysis The information about included studies was insufficient for a full assessment of quality. Data on (dis)incentives were extracted and association with recruitment tested. Main results No RCT; of interventions were identified. Eleven observational studies were included - two medical records reviews, one matched pair study, one clinician interview study, two studies documenting clinicians' decisions and five postal surveys. Three measures of recruitment were used, invitation to participate, entry into RCT and reported entry to RCT Five studies explored the effect of patient characteristics. The effect of age and prognosis varied between trials. Six studies considered the association between clinicians' views and recruitment. Clinicians who agreed to participate because they were acquainted with the researchers were less likely to participate than those otherwise motivated (1 study, 2-sided p = 0.04 Fisher's exact test) and (Odds Ratio [OR] 0.4, 95% Confidence Interval [CI] 0.2 to 0.9, 1 study). Clinicians who had recruited were more likely to report some difficulties including "trials involve extra work" (OR 92.94, 95% Cl 4.54 - 1902.11; P <= 0.0 1, 1 study) and "inviting patients to participate is embarrassing" (chi-square 15.55, df = 1, p < 0.0001, 1 study). The effect of the need to discuss clinical uncertainty was unclear but concern that the doctor-patient relationship would be adversely affected by participation was a deterrent (chi-square = 7.25, df = 1, p = 0.007, 1 study). Authors' conclusions The impact of factors varied across studies. Researchers need to be aware that aspects of the design and conduct of trials can affect clinicians' willingness to invite patients to participate. Further research is needed.
引用
收藏
页数:21
相关论文
共 31 条
[21]  
Richardson A, 2002, NEW ZEAL MED J, V115, P153
[22]   BIAS IN ANALYTIC RESEARCH [J].
SACKETT, DL .
JOURNAL OF CHRONIC DISEASES, 1979, 32 (1-2) :51-63
[23]   ENROLLMENT IN CLINICAL-TRIALS - INSTITUTIONAL FACTORS AFFECTING ENROLLMENT IN THE CARDIAC-ARRHYTHMIA SUPPRESSION TRIAL (CAST) [J].
SHEA, S ;
BIGGER, JT ;
CAMPION, J ;
FLEISS, JL ;
ROLNITZKY, LM ;
SCHRON, E ;
GORKIN, L ;
HANDSHAW, K ;
KINNEY, MR ;
BRANYON, M .
CONTROLLED CLINICAL TRIALS, 1992, 13 (06) :466-486
[24]   Factors that predict the referral of breast cancer patients onto clinical trials by their surgeons and medical oncologists [J].
Siminoff, LA ;
Zhang, A ;
Colabianchi, N ;
Sturm, CMS ;
Shen, QS .
JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (06) :1203-1211
[25]   Factors associated with breast cancer clinical trials participation and enrollment at a large academic medical center [J].
Simon, MS ;
Du, W ;
Flaherty, L ;
Philip, PA ;
Lorusso, P ;
Miree, C ;
Smith, D ;
Brown, DR .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (11) :2046-2052
[26]   Accrual to breast cancer clinical trials at a university-affiliated hospital in metropolitan Detroit [J].
Simon, MS ;
Brown, DR ;
Du, W ;
LoRusso, P ;
Kellogg, CM .
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1999, 22 (01) :42-46
[27]   FUNDAMENTAL DILEMMAS OF THE RANDOMIZED CLINICAL-TRIAL PROCESS - RESULTS OF A SURVEY OF THE 1,737 EASTERN-COOPERATIVE-ONCOLOGY-GROUP INVESTIGATORS [J].
TAYLOR, KM ;
FELDSTEIN, ML ;
SKEEL, RT ;
PANDYA, KJ ;
NG, P ;
CARBONE, PP .
JOURNAL OF CLINICAL ONCOLOGY, 1994, 12 (09) :1796-1805
[28]  
TAYLOR KM, 1985, CANCER TREAT REP, V69, P1095
[29]   PHYSICIANS REASONS FOR NOT ENTERING ELIGIBLE PATIENTS IN A RANDOMIZED CLINICAL-TRIAL OF SURGERY FOR BREAST-CANCER [J].
TAYLOR, KM ;
MARGOLESE, RG ;
SOSKOLNE, CL .
NEW ENGLAND JOURNAL OF MEDICINE, 1984, 310 (21) :1363-1367
[30]  
Wilson I, 2000, Aust Fam Physician, V29, P86